// App-Quantinova.ai

3146 : Pooled Analysis of Cardiovascular Events from Clinical Trials Evaluating Acalabrutinib Monotherapy in Patients with Chronic Lymphocytic Leukemia (CLL)

Researchers

Presenter

  • Jennifer R. Brown

Principal Investigators

  • John C. Byrd

  • Paolo Ghia

  • Jeff P Sharman

  • Peter Hillmen

  • Deborah M. Stephens

  • Clare Sun

  • Wojciech Jurczak

  • John M. Pagel

  • Alessandra Ferrajoli

  • Priti Patel

  • Marshall Baek

  • Tamara Lezhava

  • Nataliya Kuptsova-Clarkson

  • Javid J. Moslehi

  • Richard R. Furman

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy

  • Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR

  • St. James's University Hospital, Leeds, United Kingdom

  • University of Utah-Huntsman Cancer Institute, Salt Lake City, UT

  • National Heart, Lung and Blood Institute, Bethesda, MD

  • Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland

  • Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute,Seattle,Estados Unidos

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

  • Acerta Pharma, South San Francisco, CA

  • AstraZeneca, Gaithersburg, MD

  • Vanderbilt University, Nashville, TN

  • Morton Coleman, M.D. Distinguished Professor of Medicine Weill Cornell Medical College, New York, NY

Locations

  • United States

  • Italy

  • United Kingdom

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Chronic Lymphocytic Leukemia

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • ACP-196

Outcome

  • N/A

Study Design

  • Cross Over

Phase

  • NA

Study Id's

  • NCT02475681]

  • NCT02970318]

  • NCT02477696

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved